Skip to main content
Quest Diagnostics

Generic Protocols for the Analytical Validation of Next-Generation Sequencing-Based Circulating Tumor DNA Assays, Version 2.0

Generic Protocols for the Analytical Validation of Next-Generation Sequencing-Based Circulating Tumor DNA Assays, Version 2.0

Authors: Silvestro A, Baden J, Billings K, Bramlett K, Corner A, Danek T, Deras I, Dickey J, Godsey JH, Guan L, Hutchinson T, Johann DJ, Lee JSH, Lin CJ, Lococo JS, Lopez Ramos D, Richardson AO, Stetson D, Wenz P, Leiman LC

Citation: JCO Precis Oncol. 2026 May 11:e2501243. doi: 10.1200/PO-25-01243. Online ahead of print.

Specialties: Oncology, Genetics

Related content

Publication
Budget Impact Analysis of Circulating Tumor DNA Testing for Colon Cancer in Commercial Health and Medicare Advantage Plans
Audio Podcast
Enhancing Cancer Treatment Decisions With Ultrasensitive MRD Testing
Test FAQ
Haystack MRD Testing
Publication
Analytical Validation of Blood-Derived Tumor Mutation Burden (bTMB) Assays: A Joint Consensus Recommendation of the BLOODPAC bTMB Analytical Validation Working Group
Publication
Establishing a Common Lexicon for Circulating Tumor DNA Analysis and Molecular Residual Disease: Insights From the BLOODPAC Consortium
Publication
Tracking Response to Neoadjuvant Systemic Therapy Through Circulating Tumor DNA Analysis in Breast Cancer
Audio Podcast
Optimize Oncology Care with Clinical Pathways
Publication
Advanced Minimal Residual Disease Detection Using a Novel Circulating Tumor DNA Assay: A Report of Two Cases

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.